How AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion Pharma

investors.com/news/technology/astrazeneca-azn-breast-cancer-treatment-asco

Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.
The post How AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion Pharma appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-02 12:00:58.
The Entire Business World on a Single Page. Free to Use →